XML 66 R51.htm IDEA: XBRL DOCUMENT v3.25.1
Derivative financial instruments (Tables)
 12 Months Ended
Dec. 31, 2024
Text Block 1 [Abstract]  
Summary of Derivative Financial Instruments
Purpose
  
Risk
    
Instrument
   
Notional
     
Settlement date
     
12.31.2024
    
12.31.2023
  
Cash flow hedge designated as hedge accounting
         
 
(17.6
) 
  
 
8.9
 
              
 
 
    
 
 
  
Payroll expenses settled in Brazilian reais
      Exchange rate      Zero-cost collar derivative financial instruments, with purchase of put options at the exercise price of R$5.00 and sale of call options at the weighted average exercise price of R$5.48      —         2024        —        8.9  
      Zero-cost collar derivative financial instruments, with purchase of put options at the exercise price of R$5.42 and sale of call options at the weighted average exercise price of R$6.73      456.6        2025        (17.6 )      —   
              
 
 
    
 
 
  
Others derivatives not designated as hedge accounting
         
 
(73.0
) 
  
 
(116.6
) 
              
 
 
    
 
 
  
Export
      Exchange rate     
Non-Deliverable
forwards to exchange euro currency debt to US dollar currency.		      —         2024        —        (0.1 ) 
Export
      Exchange rate     
Non-Deliverable
forwards to exchange euro currency debt to US dollar currency.		      60.0        2025        2.5       —   
Equity
      Share price:
ticker EMBR3		  
 		    Equity swap      —         2024        —        8.5  
Equity (i)
     Share price:
ticker EMBR3		  
 		    Equity swap      53.9        2025        10.5       —   
Equity (ii)
     Share price:
ticker EVEX		  
 		    Private warrants      14.2        2027        (7.0 )      (14.0 ) 
Equity (ii)
     Share price:
ticker EVEX		  
 		    Public warrants      8.2        2027        (4.0 )      (11.3 ) 
Equity (iii)
     Share price:
ticker EVEX		  
 		    Strategic warrants      32.5        2027        (75.0 )      (99.7 ) 
              
 
 
    
 
 
  
              
 
(90.6
) 
  
 
(107.7
) 
              
 
 
    
 
 
  
     
Assets
           
      Current            13.2       17.5  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
Liabilities
           
      Current            (71.9 )      (85.7 ) 
     
Non-current
            (31.9 )      (39.5 ) 
              
 
 
    
 
 
  
     
Net derivative financial instruments
         
 
(90.6
) 
  
 
(107.7
) 
              
 
 
    
 
 
  
 
(i)
In April 2024, the Company entered into
18-month
swap contracts with Banco Santander S.A. Under these contracts, the Company will receive the price variation on 3,290,230 shares issued by Embraer (EMBR3) and will pay CDI plus 0.80% p.a. on the notional amount.
Additionally, in December 2024, the Company entered into
12-month
swap contracts with Banco Itaú S.A. Under these contracts, the Company will receive the price variation on 4,032,300 shares issued by Embraer (EMBR3) and will pay CDI plus 0.70% p.a. on the notional amount.
As of December 31, 2024, the Company had no margin calls related to these derivative financial instruments.
 
(ii)
Refers to the 8,203,407 (2023: 11,499,879) public warrants and 14,250,000 (2023: idem) private warrants issued by Eve Holding with a strike price of US$ 11.50 (eleven dollars and fifty cents) per share. The exercise period for these warrants will expire on the date that occurs first: May 9, 2027, the date set by the issuer to redeem all warrants or liquidation of the issuer.
The public warrants are listed and traded on the NYSE under the ticker EVEX.WS, and their fair value is derived directly from observable market prices. The fair value is calculated by multiplying the unit price of the option by the number of options. The private warrants have similar terms as the public warrants, except for the US$0.01 (one cent) cash redemption feature. The fair value measurement of the private warrants is identical to that of the public warrants since the differences between them do not affect their fair value.
 
(iii)
Refers to the 32,522,536 (2023: 37,422,536) strategic warrants units issued by Eve Holding under the following conditions:
 
  •  
Penny warrants: 20,522,536 (2023: 20,422,536) units with an exercise price of US$0.01 (one cent) per share. The fair value measurement of this instrument considers the fair value of the EVEX share minus the exercise price. Furthermore, when the exercise of the option is conditioned on the occurrence of future events, the probability of these events occurring is also considered in the measurement.
 
  •  
Market warrants: 12,000,000 (2023: 17,000,000) units with an exercise price of US$15.00 (fifteen dollars) per share. The Black-Scholes pricing model is used to measure the fair value of these financial instruments. In July 2024, 5,000,000 units with an exercise price of US$11.50 (eleven dollars and fifty cents) were extinguished as a result of the capital contribution made to Eve Holding. See further information in Note 2.3.1.
Summary of Other Comprehensive Income Related to Cash Flow Hedge
The amount reported in other comprehensive income related to cash flow hedge is detailed as follows:
 
    
12.31.2024
     
12.31.2023
     
12.31.2022
  
Changes in fair value
         
Gain hedging reserve
      —         7.4        —   
(Loss) gain cost of hedging reserve
      (17.6 )       1.6        2.3  
Deferred tax
      6.0        —         —   
Reclassification to profit or loss
         
Fair value
      (8.9 )       (2.5 )       1.2  
Other reclassifications
      (4.2 )       0.8        0.7  
  
 
 
     
 
 
     
 
 
  
Total reported in other comprehensive income
   
 
(24.7
) 
   
 
7.3
 
   
 
4.2